These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9739030)

  • 1. Parenteral glutamine infusion alters insulin-mediated glucose metabolism.
    Borel MJ; Williams PE; Jabbour K; Levenhagen D; Kaizer E; Flakoll PJ
    JPEN J Parenter Enteral Nutr; 1998; 22(5):280-5. PubMed ID: 9739030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.
    Galassetti P; Shiota M; Zinker BA; Wasserman DH; Cherrington AD
    Am J Physiol; 1998 Jul; 275(1):E101-11. PubMed ID: 9688880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal venous 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output.
    Camacho RC; Pencek RR; Lacy DB; James FD; Donahue EP; Wasserman DH
    Diabetes; 2005 Feb; 54(2):373-82. PubMed ID: 15677495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon response to exercise is critical for accelerated hepatic glutamine metabolism and nitrogen disposal.
    Krishna MG; Coker RH; Lacy DB; Zinker BA; Halseth AE; Wasserman DH
    Am J Physiol Endocrinol Metab; 2000 Sep; 279(3):E638-45. PubMed ID: 10950833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of glutamine supplementation on glucose homeostasis during and after exercise.
    Iwashita S; Williams P; Jabbour K; Ueda T; Kobayashi H; Baier S; Flakoll PJ
    J Appl Physiol (1985); 2005 Nov; 99(5):1858-65. PubMed ID: 16037406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
    Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atropine and gastric inhibitory polypeptide on hepatic glucose uptake and insulin extraction in conscious dogs.
    Chap Z; Ishida T; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1985 Sep; 76(3):1174-81. PubMed ID: 3900134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
    Nishizawa M; Moore MC; Shiota M; Gustavson SM; Snead WL; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1027-36. PubMed ID: 12569088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.
    Moore MC; Kimura K; Shibata H; Honjoh T; Saito M; Everett CA; Smith MS; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E225-31. PubMed ID: 15755767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of ammonium ions in regulating hepatic glutamine synthesis during fasting.
    Cersosimo E; Williams P; Geer R; Lairmore T; Ghishan F; Abumrad NN
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E514-9. PubMed ID: 2801934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of metabolism of viscera drained by the portal vein in neonatal calves, using short-term intravenous infusions of glutamine and other nutrients.
    Nappert G; Zello GA; Ferguson J; Naylor JM
    Am J Vet Res; 1999 Apr; 60(4):437-45. PubMed ID: 10211686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glutamine in adaptations in nitrogen metabolism during fasting.
    Cersosimo E; Williams PE; Radosevich PM; Hoxworth BT; Lacy WW; Abumrad NN
    Am J Physiol; 1986 Jun; 250(6 Pt 1):E622-8. PubMed ID: 3521309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production.
    Ader M; Bergman RN
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E1020-32. PubMed ID: 2193527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal.
    Dicostanzo CA; Dardevet DP; Neal DW; Lautz M; Allen E; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E9-E16. PubMed ID: 16105863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intraportal N(omega)-nitro-L-arginine infusion on hepatic glucose metabolism in total parenteral nutrition-adapted dogs: interaction with infection.
    Chen SS; Donmoyer CM; Ejiofor J; McCay J; Archuletta R; Lacy DB; McGuinness OP
    Metabolism; 2002 Mar; 51(3):274-83. PubMed ID: 11887160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region.
    Dardevet D; Moore MC; Neal D; DiCostanzo CA; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E75-81. PubMed ID: 15026303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E380-4. PubMed ID: 18056788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.